# Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single-dose Injection of SHR-2004 in Healthy Subjects

> **NCT05369767** · PHASE1 · UNKNOWN · sponsor: **Beijing Suncadia Pharmaceuticals Co., Ltd** · enrollment: 64 (actual)

## Conditions studied

- Prevention of Arterial and Venous Thrombosis

## Interventions

- **DRUG:** SAD, SHR-2004
- **DRUG:** SAD, SHR-2004 placebo

## Key facts

- **NCT ID:** NCT05369767
- **Lead sponsor:** Beijing Suncadia Pharmaceuticals Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-24
- **Primary completion:** 2023-01-30
- **Final completion:** 2023-01-30
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2022-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05369767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05369767, "Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single-dose Injection of SHR-2004 in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05369767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*